Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 50.27% | 60.74% | 87.45% | 83.54% | 36.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.27% | 60.74% | 87.45% | 83.54% | 36.70% |
| Cost of Revenue | 48.18% | 58.70% | 84.35% | 75.68% | 35.34% |
| Gross Profit | 57.87% | 68.92% | 100.16% | 132.75% | 41.90% |
| SG&A Expenses | 48.82% | -0.78% | 18.05% | -9.52% | -31.38% |
| Depreciation & Amortization | 1,414.01% | 1,761.52% | 264.22% | 107.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.51% | 55.01% | 66.50% | 49.50% | 12.95% |
| Operating Income | -670.20% | 0.87% | 66.39% | 66.58% | 107.85% |
| Income Before Tax | 21.15% | -208.48% | 249.01% | 27.48% | -71.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.15% | -208.48% | 249.01% | 27.48% | -71.62% |
| Earnings from Discontinued Operations | -- | -- | 86.82% | -45.79% | 1,726.11% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.26% | -180.95% | 161.67% | 9.80% | 3,038.38% |
| EBIT | -670.20% | 0.87% | 66.39% | 66.58% | 107.85% |
| EBITDA | 106.59% | 215.58% | 125.99% | 94.19% | 134.44% |
| EPS Basic | -112.39% | -165.22% | 157.67% | 16.36% | 2,885.20% |
| Normalized Basic EPS | -265.38% | -16.09% | 101.60% | 88.47% | -- |
| EPS Diluted | -112.98% | -165.22% | 157.67% | 19.27% | 2,874.00% |
| Normalized Diluted EPS | -265.38% | -16.09% | 101.60% | 88.47% | -- |
| Average Basic Shares Outstanding | 7.06% | 6.05% | 6.80% | 7.84% | 5.65% |
| Average Diluted Shares Outstanding | 7.06% | 6.05% | 12.86% | 7.84% | 5.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |